Histone modifications and skeletal muscle metabolic gene expression
- 23 February 2010
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 37 (3) , 392-396
Abstract
Summary: 1. Skeletal muscle oxidative function and metabolic gene expression are co‐ordinately downregulated in metabolic diseases such as insulin resistance, obesity and Type 2 diabetes. Altering skeletal muscle metabolic gene expression to favour enhanced energy expenditure is considered a potential therapy to combat these diseases.2. Histone deacetylases (HDACs) are chromatin‐remodelling enzymes that repress gene expression. It has been shown that HDAC4 and 5 co‐operatively regulate a number of genes involved in various aspects of metabolism. Understanding how HDACs are regulated provides insights into the mechanisms regulating skeletal muscle metabolic gene expression.3. Multiple kinases control phosphorylation‐dependent nuclear export of HDACs, rendering them unable to repress transcription. We have found a major role for the AMP‐activated protein kinase (AMPK) in response to energetic stress, yet metabolic gene expression is maintained in the absence of AMPK activity. Preliminary evidence suggests a potential role for protein kinase D, also a Class IIa HDAC kinase, in this response.4. The HDACs are also regulated by ubiquitin‐mediated proteasomal degradation, although the exact mediators of this process have not been identified.5. Because HDACs appear to be critical regulators of skeletal muscle metabolic gene expression, HDAC inhibition could be an effective therapy to treat metabolic diseases.6. Together, these data show that HDAC4 and 5 are critical regulators of metabolic gene expression and that understanding their regulation could provide a number of points of intervention for therapies designed to treat metabolic diseases, such as insulin resistance, obesity and Type 2 diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Identification of Histone H3 Lysine 36 Acetylation as a Highly Conserved Histone ModificationJournal of Biological Chemistry, 2007
- Peroxisome Proliferator-Activated Receptor γ Coactivator 1 Coactivators, Energy Homeostasis, and MetabolismEndocrine Reviews, 2006
- Cardiovascular Risk Factors Emerge After Artificial Selection for Low Aerobic CapacityScience, 2005
- Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1Proceedings of the National Academy of Sciences, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Control of muscle development by dueling HATs and HDACsCurrent Opinion in Genetics & Development, 2001
- The language of covalent histone modificationsNature, 2000
- Activation of PPARγ Coactivator-1 Through Transcription Factor DockingScience, 1999
- TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINSAnnual Review of Cell and Developmental Biology, 1998
- The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes, 1988